Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas.
Guzzo F, Bellone S, Buza N, Hui P, Carrara L, Varughese J, Cocco E, Betti M, Todeschini P, Gasparrini S, Schwartz PE, Rutherford TJ, Angioli R, Pecorelli S, Santin AD. Guzzo F, et al. Among authors: todeschini p. Int J Gynecol Pathol. 2012 May;31(3):211-21. doi: 10.1097/PGP.0b013e31823bb24d. Int J Gynecol Pathol. 2012. PMID: 22498937 Free PMC article.
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.
Cocco E, Hu Z, Richter CE, Bellone S, Casagrande F, Bellone M, Todeschini P, Krikun G, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Buza N, Pecorelli S, Lockwood CJ, Santin AD. Cocco E, et al. Among authors: todeschini p. Br J Cancer. 2010 Sep 7;103(6):812-9. doi: 10.1038/sj.bjc.6605760. Epub 2010 Aug 10. Br J Cancer. 2010. PMID: 20700124 Free PMC article.
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody.
Varughese J, Cocco E, Bellone S, de Leon M, Bellone M, Todeschini P, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Varughese J, et al. Among authors: todeschini p. Cancer. 2011 Jul 15;117(14):3163-72. doi: 10.1002/cncr.25891. Epub 2011 Jan 18. Cancer. 2011. PMID: 21246534 Free PMC article.
Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
Richter CE, Cocco E, Bellone S, Bellone M, Casagrande F, Todeschini P, Rüttinger D, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Richter CE, et al. Among authors: todeschini p. Int J Gynecol Cancer. 2010 Dec;20(9):1440-7. Int J Gynecol Cancer. 2010. PMID: 21370592 Free PMC article.
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.
Varughese J, Cocco E, Bellone S, Bellone M, Todeschini P, Carrara L, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Varughese J, et al. Among authors: todeschini p. Gynecol Oncol. 2011 Jul;122(1):171-7. doi: 10.1016/j.ygyno.2011.03.002. Epub 2011 Mar 30. Gynecol Oncol. 2011. PMID: 21453957 Free PMC article.
Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody.
Bellone M, Cocco E, Varughese J, Bellone S, Todeschini P, El-Sahwi K, Carrara L, Guzzo F, Schwartz PE, Rutherford TJ, Pecorelli S, Marshall DJ, Santin AD. Bellone M, et al. Among authors: todeschini p. Int J Gynecol Cancer. 2011 Aug;21(6):1084-90. doi: 10.1097/IGC.0b013e3182187324. Int J Gynecol Cancer. 2011. PMID: 21633302 Free PMC article.
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.
Cocco E, Varughese J, Buza N, Bellone S, Glasgow M, Bellone M, Todeschini P, Carrara L, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Lockwood CJ, Santin AD. Cocco E, et al. Among authors: todeschini p. BMC Cancer. 2011 Jun 22;11:263. doi: 10.1186/1471-2407-11-263. BMC Cancer. 2011. PMID: 21693061 Free PMC article.
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
Cocco E, Varughese J, Buza N, Bellone S, Lin KY, Bellone M, Todeschini P, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Carrara L, Tassi R, Pecorelli S, Lockwood CJ, Santin AD. Cocco E, et al. Among authors: todeschini p. Clin Exp Metastasis. 2011 Oct;28(7):689-700. doi: 10.1007/s10585-011-9401-0. Epub 2011 Jul 2. Clin Exp Metastasis. 2011. PMID: 21725665 Free PMC article.
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody.
Raji R, Guzzo F, Carrara L, Varughese J, Cocco E, Bellone S, Betti M, Todeschini P, Gasparrini S, Ratner E, Silasi DA, Azodi M, Schwartz P, Rutherford TJ, Buza N, Pecorelli S, Santin AD. Raji R, et al. Among authors: todeschini p. J Exp Clin Cancer Res. 2011 Nov 10;30(1):106. doi: 10.1186/1756-9966-30-106. J Exp Clin Cancer Res. 2011. PMID: 22075385 Free PMC article.
93 results